AI In Genomics Market Report 2026

AI In Genomics Market Overview

• AI In Genomics market size has reached to $1.51 billion in 2025 • Expected to grow to $9.32 billion in 2030 at a compound annual growth rate (CAGR) of 43.7% • Growth Driver: The Rise In Personalized Medicine Driving Market Growth Due To Increasing Adoption For Chronic And Complex Disease Management • Market Trend: Innovative Technologies Transform Drug Discovery And Genetic Disease Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under AI In Genomics Market?

AI in genomics is a set of computer tools used by genomics researchers to manage and understand any important information concealed in big datasets for DNA sequencing and other biological procedures. These algorithms are capable of detecting human genetic patterns and abnormalities in genomic data. The main components used in AI in genomics are hardware, software, and services, with machine learning and computer vision as the main technologies involved. Hardware refers to the exterior and internal components and equipment that allow users to accomplish major operations such as input, output, storage, communication, processing, and more. The main functionalities are genome sequencing, gene editing, and others, which are used for several applications, including drug discovery and development, precision medicine, diagnostics, and others. The major end-users included are pharmaceutical and biotech companies, healthcare providers, research centers, and others.

What Is The AI In Genomics Market Growth Forecast?

The AI in genomics market size is expected to see exponential growth in the next few years. It will grow to $9.32 billion in 2030 at a compound annual growth rate (CAGR) of 43.7%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising investments in ai-powered drug discovery, expansion of population genomics projects, growing demand for personalized healthcare solutions, advancements in deep learning genomic models. Major trends in the forecast period include increasing adoption of ai-driven genome analysis platforms, rising use of machine learning for variant detection, growing integration of AI in gene editing workflows, expansion of cloud-based genomic data processing, enhanced focus on high-accuracy pattern recognition.

Global AI In Genomics Market Segmentation

1) By Component: Hardware, Software, Services 2) By Technology: Machine Learning, Computer Vision 3) By Functionality: Genome Sequencing, Gene Editing, Other Functionalities 4) By Application: Drug Discovery And Development, Precision Medicine, Diagnostics, Other Applications 5) By End-Use: Pharmaceutical And Biotech Companies, Healthcare Providers, Research Centers, Other End-Users Subsegments: 1) By Hardware: Servers, Storage Devices, Networking Equipment 2) By Software: Data Analysis Software, Machine Learning Algorithms, Visualization Tools, Genomic Data Management Software 3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Analytics Services

What Is The Driver Of The AI In Genomics Market?

The increasing usage of personalized medicine approaches is expected to propel the growth of AI in the genomics market going forward. Personalized medicine, also known as precision medicine, is a novel approach to medical treatment and healthcare that takes individual variations in patients' genes, surroundings, and lifestyles into consideration. The growing adoption of personalized medicine is due to the rising prevalence of chronic and complex diseases, as these approaches allow treatments to be tailored to individual patient profiles, improving effectiveness and reducing adverse effects. AI in genomics accelerates the analysis of complex genetic data, enabling personalized medicine by tailoring treatments and interventions to an individual’s unique genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. Therefore, the increasing usage of personalized medicine approaches is driving the AI in genomics industry.

Key Players In The Global AI In Genomics Market

Major companies operating in the AI in genomics market are International Business Machines Corporation; Microsoft Corp.; NVIDIA Corporation; Deep Genomics Inc.; BenevolentAI Ltd.; Fabric Genomics Inc.; Verge Genomic Inc.; Freenome Holdings Inc.; MolecularMatch Inc.; SOPHiA GENETICS SA; Data4Cure Inc.; PrecisionLife Ltd.; Genoox Ltd.; Lifebit Ltd.; Empiric Logic Ltd.; FDNA Inc.; DNAnexus Inc.; Engine Biosciences Pte Ltd.; 4baseCare; Congenica Ltd.; CytoReason Ltd.; Emedgene Technologies LTD; Illumina Inc.; Lifebit Biotech Ltd.; Mendel.ai; Predictive Oncology Inc.; Tempus Labs Inc.; 10x Genomics Inc.; Repositive Limited; Genedata AG; Global Gene Corp; Nference Inc.; Bluebee Holding B.V.; Genomenon Inc.

Global AI In Genomics Market Trends and Insights

Major companies in the AI in genomics market are focusing on developing innovative solutions, such as drug discovery platforms, to enhance precision healthcare and research efficiency. A drug discovery platform is a technology or software system that uses computational tools, AI, or lab automation to identify, design, and optimize new drug candidates efficiently. For instance, in March 2023, Genomic Vision, a France-based biotechnology company that specializes in the development of diagnostic solutions for genetic diseases and cancers, launched FiberSmart, an AI-powered software that enables the visualization and analysis of long DNA fibers at high resolution. It has the potential to completely change the diagnosis and treatment of genetic illnesses. It was introduced to increase the precision and effectiveness of diagnosing and treating genetic diseases. Large amounts of data are analyzed using this technology to find patterns and insights that would be impossible for humans to find on their own.

What Are Latest Mergers And Acquisitions In The AI In Genomics Market?

In September 2025, SeqOne S.A.S., a France-based healthcare technology company, acquired Congenica for an undisclosed amount. With this acquisition, SeqOne aims to strengthen its global leadership in AI-powered genomic medicine by combining advanced AI analytics with trusted clinical interpretation services. Congenica Ltd is a UK-based healthcare technology company that specializes in providing AI in genomics.

Regional Insights

North America was the largest region in the AI in genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the AI in the genomics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the AI In Genomics Market?

The AI in genomics market includes revenues earned by entities by providing services such as computer vision, time series analysis, automatic speech recognition, and natural language processing. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in genomics market also includes sales of neural network hardware, powered diagnostics and imaging machine which are used in providing AI in genomics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Genomics Market Report 2026?

The ai in genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.